Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024312 (
lymphopenia
)
4,859
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although C57BL/KsJ db/db mice, an animal model of non-insulin-dependent diabetes mellitus (NIDDM), develop T
lymphopenia
in association with the progression of NIDDM, the T
lymphopenia
has not been fully investigated. In this study, to elucidate how and why T
lymphopenia
develops in db/db mice, T-lymphocyte subsets in spleen and thymus were longitudinally examined by flow cytometry and the effects of thymectomy and dietary restriction on the development of T
lymphopenia
were evaluated. After 8 weeks of age, when obese diabetes progresses, T
lymphopenia
in both spleen and thymus developed and all T-lymphocyte subsets examined were similarly reduced compared to lean (-/X) littermates, indicating non-selective T
lymphopenia
in db/db mice. Thymectomy performed at 5 wk of age, when neither T
lymphopenia
nor NIDDM yet presents, had no significant effect on the development of T
lymphopenia
. Furthermore, pair feeding until 30 weeks of age produced normal body weight and normoglycemia with still marked
hyperinsulinemia
, but failed to correct T
lymphopenia
in db/db mice. In conclusion, our results suggest that T
lymphopenia
may develop non-selectively and independently of either thymic dysfunction or obese diabetes in db/db mice.
...
PMID:T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. 957 Mar 39